These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 130138)
1. [On the multiple-dose kinetics of glibornuride in man (author's transl)]. Dubach UC; Korn A; Raaflaub J Arzneimittelforschung; 1975; 25(12):1967-9. PubMed ID: 130138 [TBL] [Abstract][Full Text] [Related]
2. Clinical comparison between glibornuride (Glutril) and glibenclamide in maturity-onset diabetes: a controlled double-blind trial. Mogensen EF; Worm J; Mikkelsen BO Curr Ther Res Clin Exp; 1976 Jun; 19(6):559-64. PubMed ID: 132338 [No Abstract] [Full Text] [Related]
3. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride]. Herrlinger H; Dörfler H; Wolfram G; Zöllner N Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895 [No Abstract] [Full Text] [Related]
4. Clinical comparison between glibornuride (Glutril) and tolbutamide in maturity-onset diabetes: a controlled double-blind trial. Lindbjerg IF; Christoffersen EM; Kuusisto A; Lodahl K; Sagild U; Sterling N; Mikkelsen BO Curr Ther Res Clin Exp; 1976 Sep; 20(3):277-82. PubMed ID: 134878 [No Abstract] [Full Text] [Related]
5. [Further results of a multi-centre clinical trial with the oral antidiabetic drug glisoxepide (author's transl)]. Blumenbach L; Kiesselbach N; Lehnert J Arzneimittelforschung; 1976; 26(5):931-43. PubMed ID: 786303 [TBL] [Abstract][Full Text] [Related]
6. [Clinico-pharmacological studies on the duration of action of the oral antidiabetic drug glisoxepide (author's transl)]. Gutsche H; Losert W Arzneimittelforschung; 1977; 27(9):1719-26. PubMed ID: 336058 [No Abstract] [Full Text] [Related]
7. [Our modification of the method of determining plasma glibornuride and the evaluation of its usefulness in clinical and pharmacological studies]. Nasierowska Z; Suffczyński J; Szyszko E; Deres J; Tatoń J; Koliński P; Wojterska J; Leowski J Pol Tyg Lek; 1982 Dec; 37(51-52):1559-63. PubMed ID: 6223286 [No Abstract] [Full Text] [Related]
8. Lack of effect of tenoxicam on glibornuride kinetics and response. Stoeckel K; Trueb V; Dubach UC; Heintz RC; Ascalone V; Forgo I; Hennes U Br J Clin Pharmacol; 1985 Feb; 19(2):249-54. PubMed ID: 3157397 [TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic of glipentide (UR-661) by IV. administration on healthy and diabetic volunteers (author's transl)]. Rimbau Barreras V; Uriach Marsal J; Pou Torelló JM Arch Farmacol Toxicol; 1976 Aug; 2(2):115-22. PubMed ID: 791156 [No Abstract] [Full Text] [Related]
10. [Clinical experience with RO 6-4563 (Glibornuride) (a new oral hypoglycemic agent)]. Rodríguez-Miñón JL; Herrera Pombo JL; Marrón JA Rev Clin Esp; 1971 Dec; 123(5):439-42. PubMed ID: 5160567 [No Abstract] [Full Text] [Related]
11. Long term treatment of diabetes mellitus with glibornuride. A new hypoglycemic agent. Nava M; Quibrera R; Pérez Arocha N Rev Invest Clin; 1973; 25(2):169-74. PubMed ID: 4198609 [No Abstract] [Full Text] [Related]
13. [Clinical comparison between glibornuride (Glutril) and glibenclamide in senile diabetes. A controlled double-blind trial]. Mogensen EF; Worm J; Mikkelsen BO Ugeskr Laeger; 1976 Jun; 138(26):1569-71. PubMed ID: 133484 [No Abstract] [Full Text] [Related]
14. [Clinical comparison between glibornuride (Glutril) and tolbutamide in senile diabetes. A controlled doblle-blind trial]. Lindbjerg IF; Christoffersen EM; Kuusisto A; Lodahl K; Saglid U; Sterling N; Mikkelsen BO Ugeskr Laeger; 1976 Jun; 138(26):1572-4. PubMed ID: 133485 [No Abstract] [Full Text] [Related]
15. A clinical trial of glibornuride in maturity-onset diabetes mellitus. Tandhanand S; Vannasaeng S; Aswapokee N; Soongsavang V; Aphonsuvan S J Med Assoc Thai; 1974 May; 57(5):232-6. PubMed ID: 4832761 [No Abstract] [Full Text] [Related]
16. A phase I and pharmacokinetic study of ILX-295501, an oral diarylsulfonylurea, on a weekly for 3 weeks every 4-week schedule in patients with advanced solid malignancies. Forouzesh B; Takimoto CH; Goetz A; Diab S; Hammond LA; Smetzer L; Schwartz G; Gazak R; Callaghan JT; Von Hoff DD; Rowinsky EK Clin Cancer Res; 2003 Nov; 9(15):5540-9. PubMed ID: 14654534 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers. Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580 [TBL] [Abstract][Full Text] [Related]
18. [Clinical study of a new sulfonylurea antidiabetic, glibornuride]. Vernet A; Fabre J; Zahnd G Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563 [No Abstract] [Full Text] [Related]
19. [Treatment of adult diabetes with semi-euglucon (author's transl)]. Schäfer D; Molck H MMW Munch Med Wochenschr; 1979 Mar; 121(11):393-6. PubMed ID: 107413 [TBL] [Abstract][Full Text] [Related]
20. [Glibornuride--field study on an oral antidiabetic agent. Results of therapy with gluboride in a large number of patients]. Schmitt EW; Nijssen J Med Welt; 1978 Jul; 29(29-30):1170-4. PubMed ID: 149889 [No Abstract] [Full Text] [Related] [Next] [New Search]